Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Prevention of In-Stent Restenosis in T2DM (PIPER)
NCT00376870Phase 3Unknown
- Sponsor
- University of Rome Tor Vergata
- Start
- Jul 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in coronary restenosis, sponsored by University of Rome Tor Vergata. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
coronary restenosis
Beyond the preview
Go deeper on NCT00376870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376870.